CAS Pharmaceutical Medicine | |
Location | Basel, North West Switzerland, Switzerland |
Category | Health Pharmacology |
type | CAS |
The Certificate of Advanced Studies (CAS) in Pharmaceutical Medicines program provides specialist knowledge in the field of drug development at an advanced level. The syllabus of the course program covers all aspects of pharmaceutical medicine and drug development as defined by the International Federation of Associations of Pharmaceutical Physicians IFAPP . This includes the discovery and development of new medicines, clinical trial methodology, good clinical practice and ethics, pharmacovigilance and epidemiology, biostatistics, regulatory affairs, health economics, project management, marketing and new therapeutic approaches. The CAS program concludes with a multiple choice examination and is worth 20 ECTS. The ECPM belongs to the Department of Public Health of the Medical Faculty at the University of Basel and is accredited as "Centre of Excellence" by the Innovative Medicines Initiative (IMI) PharmaTrain Executive Board. All ECPM courses are accredited by IMI PharmaTrain and the International Federation of Associations of Pharmaceutical Physicians (IFAPP) by following the agreed syllabus and quality assurance, and are certified by the University of Basel within the Bologna Title System. The course program is divided into six modules consisting of four days each over a period of two years. Learning methods comprise online preparation, lectures and group work on case studies. The course language is English. The ECPM Advanced Studies degrees are targeted at representatives from the pharmaceutical industry, service industry, academic and government decision- and policy-makers who already have a good understanding of the basics of drug development and will benefit from a more in-depth, comprehensive and systematic immersion into modern medical product and device development, regulation and market introduction. In order to enroll for a Certificate of Advanced Studies in Pharmaceutical Medicine, applicants must have a higher university degree, such as a Master’s, MD, PharmD or PhD. Applicants should have a primary interest in medical product discovery, development, regulation and health care system. The program is particularly aimed at professionals who are involved in the drug development process and have already at least one to two years working experience. Applications sur dossier are possible on an individual basis. The ECPM teaching faculty consists of an international network of about +150 experts from academia, pharmaceutical industry, international organizations (e[.]g. WHO) and from regulatory authorities (e.g. EMA, FDA and local authorities). European Center of Pharmaceutical Medicine (ECPM)
Phone 0041 (0)61 207 19 50
The tuition fee for the entire course amounts to CHF 14’750. A reduced fee of CHF 10’500 applies to non-profit organizations. The tuition fee includes o Online course material o Lunches and coffee breaks and a welcome aperitif per module o Access to the online media library o Fee for the multiple choice questions (MCQ) exam (Certificate of Advanced Studies) Not included are the printed course materials, which are provided for CHF 500 and can be ordered optionally. DATE Module 1 - Global Drug Development and Pharmaceutical Business Environment: August 28 - 31, 2023
Examination Multiple Choice - August 19, 2025 REGISTRATION
European Center of Pharmaceutical Medicine (ECPM) Institute of Pharmaceutical Medicine University of Basel Klingelbergstrasse 61 CH-4056 Basel | |
In your contacts, please refer to myScience.ch and reference edu.myScience.ch/id3666 |
Related Job Offers
- 06.11.24 - Responsable de la filière à 100% - Genève
- 21.10.24 - Assistant-e doctorant-e à 80% - 100% - Genève
- 17.10.24 - 3 Wissenschaftliche Mitarbeitende Kompetenzzentrum Versorgungssicherheit - Liebefeld
- 15.10.24 - Postdoc Scientist in Clinical Bioinformatics (80-100 %) - Muttenz
- 02.10.24 - Associate Professor or Assistant Professor with Tenure Track in the Field of Genetics/Epigenetics of Language Development - Genève
Related News
6 November 2024
’Gene desert’ regulates embryonic development and cardiac function
4 November 2024
The devastating effects of cocaine, even among young people
31 October 2024
Unraveling the Link Between Hepatitis and Kidney Damage